Hepatitis c Cure's safety checked in people on other drugs
NCT ID NCT07419347
Summary
This study looks back at real-world medical records to check the safety and effectiveness of an 8-week hepatitis C treatment (Glecaprevir/Pibrentasvir) in people who are also taking other prescription medications or illicit drugs. It aims to see how well the treatment works and what side effects occur in this specific group. The study will include up to 2,000 people who have already been treated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C VIRUS (HCV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Clair Medical Clinic /ID# 275334
RECRUITINGToronto, Ontario, M4S 1Y2, Canada
-
Vancouver Infectious Diseases Centre /ID# 275313
NOT_YET_RECRUITINGVancouver, British Columbia, V6Z 2C7, Canada
Conditions
Explore the condition pages connected to this study.